Abstract:This study focused on the current state of the therapeutic potential of extracellular vesicles, which depends on the methods of their isolation and composition and the characteristics of the vesicular and nonvesicular components. Myocardial damage, particularly as a result of acute myocardial infarction, leads to irreversible death of cardiomyocytes and sarcomeres and ultimately to heart failure. The adult heart has limited regenerative capacity; therefore, stimulation of endogenous repair and regenerative potentials using cell therapy has potential. Moreover, the benefit from the injection of stem cells and progenitor cells into the damaged myocardium is mediated by the factors they secrete. In particular, exosomes, nanosized secreted extracellular vesicles of endosomal origin, have become key signaling organelles in intercellular communication and are currently considered key regenerative components of the secretome of stem and progenitor cells. Exosomes released from cardiac embryonic and mesenchymal stem cells, resident stem and progenitor cells (including a specific subgroup of cardiosphere cells), induced pluripotent stem cells, and cardiomyocytes isolated from these cells have cardioprotective, immunomodulatory, and reparative abilities. The use of exosomes in the targeted transport of drugs in lipid-like nanocontainers and extracellular vesicles is another promising area. Because artificial drug carriers, including liposomes and lipid-based nanoparticles, are limited by potential toxicity, immunogenicity, and inability to target specific organs, exosomes hold good promise as potential drug carriers. Compounds can be transported both inside exosomes and on their surface. Secreted extracellular vesicles, particularly exosomes, can be considered a key functional component of the secretome of stem cells and cardiogenic progenitor cells (mesenchymal stem cells, endogenous cardiac progenitor cells, cardiospheres, bone marrow embryonic stem cells, and bone marrow induced pluripotent stem cells). They have demonstrated therapeutic efficacy in preclinical models in the study of cardiovascular pathology.

Current Optimized Strategies for Stem Cell-Derived Extracellular Vesicle/exosomes in Cardiac Repair.

Concise Review: Optimized Strategies for Stem Cell-based Therapy in Myocardial Repair: Clinical Translatability and Potential Limitation.

Therapeutic Applications of Extracellular Vesicles for Myocardial Repair

Extracellular Vesicles: A New Frontier for Cardiac Repair

Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applications.

The Challenges Of Stem Cell Therapy In Myocardial Infarction And Heart Failure And The Potential Strategies To Improve The Outcomes

Targeted delivery of extracellular vesicles in heart injury

The potential mechanisms and treatment effects of stem cell-derived exosomes in cardiac reengineering

Mechanisms and Optimization Strategies of Paracrine Exosomes from Mesenchymal Stem Cells in Ischemic Heart Disease

Extracellular vesicles: Targeting the heart

Stem cell and exosome therapies for regenerating damaged myocardium in heart failure

Exosomes based strategies for cardiovascular diseases: Opportunities and challenges

Therapeutic properties of stem cell-derived exosomes in ischemic heart disease

Potential Mechanisms Underlying Therapeutic Benefits of Stem Cell for Heart Failure

Stem Cell-Derived Exosome in Cardiovascular Diseases: Macro Roles of Micro Particles

The Potential of Mesenchymal Stem Cell-Derived Exosomes in Cardiac Repair

Regenerative Therapy for Cardiomyopathies

Exosomes Derived from Embryonic Stem Cells as Potential Treatment for Cardiovascular Diseases.

Exploring Cutting-Edge Approaches to Potentiate Mesenchymal Stem Cell and Exosome Therapy for Myocardial Infarction.

Stem cell exosomes in the pathophysiology of cardiovascular diseases

Harnessing the Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Cardiac Arrest: Current Advances and Future Perspectives